Abstract:Magnetic Resonance Imaging(MRI)is a powerful method for clinical diagnosis and therapy due to the distinguishing characteristics of providing high-quality three-dimensional images of soft tissue without the need for harmful ionizing radiation.Complexes of gadolinium(Ⅲ)have proven to be especially effective M RI contrast agents,as it is estimated that they are needed for over 30% of the patients to accelerate relaxation rate of in vivo water protons,thus enhancing the contrast of different biological tissues and definition between normal tissues and diseased parts.For more sensitive small-molecule gadolinium-based M RI contrast agents,one essential requirement is to increase the hydration number q, which enhances the gadolinium's relaxivity.However,with the concern of chronic kidney disease(CKD) and nephrogenic systemic fibrosis(NSF),competition between strong chelate stability and free water coordination sites has increasingly become a challenge to M RI enhancement agent design.A highly stable N-oxide-DTPA-bisamide-based Gd(Ⅲ)complex with 3 coordinated water molecules is synthesized.The general methods such as 1 H-NMR,13C-NMR and ESI-MS spectroscopy are used to characterize the structures of the ligand and the complex.T he hydration number determined by the fluorescence lifetime of its Europium(Ⅲ)analogue is 3.M RI measurement show s much higher relaxivity value(16.39 mM -1·s-1) than commercial contrast agents.By fitting the potentiometric data with HYPERQUAD program,the formation constants of the Gd(Ⅲ)complex are calculated and demonstrated a superior stability over Gd-DTPA-BMA(Omniscan?).Meanwhile,in vivo imaging shows good imaging quality and cell tests reveal low cytotoxicity of the complexes,which indicate its great potential for future clinical applications.

Comparison Between Gd-Dtpa and Several Bisamide Derivatives As Potential Mri Contrast Agents

Nmr Studies of Gd(Dtpa-Bin) in Human Serum Albumin Solution

Studies of Gd-Diethylenetriamine Pentaacetic Acid in Boving Serum Albumin Solution by Nuclear Magnetic Resonance Spectroscopy

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

The gadolinium complexes with polyoxometalates as potential MRI contrast agents.

Synthesis and evaluation of Gd-DTPA-labeled arabinogalactans as potential MRI contrast agents

An Evaluation of Gadolinium Polyoxometalates As Possible MRI Contrast Agent.

Synthesis and Evaluation of Neutral Gd(III), Mn(II) Complexes from DTPA-Bisamide Derivative As Potential MRI Contrast Agents

Synthesis and preliminary evaluation of gadolinium complexes containing sulfonamide groups as potential MRI contrast agents

Synthesis and Evaluation of Aromatic Dtpa-Bis(Amide) Gadolinium Complexes As Magnetic Resonance Imaging Contrast Agents

Evaluation of Dendritic Gadolinium Complexes as MRI Contrast Agents

Rational Design of Gd-DOTA-Type Contrast Agents for Hepatobiliary Magnetic Resonance Imaging

Synthesis of a Highly Stable Gadolinium Based MRI Contrast Agent

Gadolinium-based contrast agents for tumor targeting imaging

Synthesis, Relaxivity And Biodistribution Of Novel Magnetic Resonance Imaging (Mri) Contrast Agents: Polylysine (Gd-Dtpa/Dota) With Pendent Galactose Moieties As Hepatocyte-Targeting Groups

Arabinogalactan As A Carrier for Contrast Agent in Magnetic Resonance Imaging

Bi-DTPA As a High-Performance CT Contrast Agent for in Vivo Imaging.

Studies on D-galactose-containing DTPA bisamide gadolinium complexes as liver-targeting MRI contrast agents

Synthesis and evaluation of novel polysaccharide-Gd-DTPA compounds as contrast agent for MRI

A Biocompatible Gadolinium-Based Amino Acid Copolymer Contrast Agent for Magnetic Resonance Imaging

Synthesis and relaxation properties of lanthanide(Gd,Yb) complexes with tris modified DTPA